Granules India Acquires Swiss CDMO Senn Chemicals AG for ₹192 crore
February 22, 2025
Granules India Limited has agreed to acquire Senn Chemicals AG, a Swiss peptide-focused CDMO, for ₹192 crore, with closing subject to conditions expected in the first half of 2025. The deal gives Granules peptide R&D and cGMP manufacturing capabilities and access to regulated-market customers as it expands into peptide therapeutics and related end-markets.
- Buyers
- Granules India Limited
- Targets
- Senn Chemicals AG
- Industry
- Pharmaceuticals
- Location
- Zurich, Switzerland
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.